Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study. [electronic resource]
Producer: 20180326Description: 1148-1154 p. digitalISSN:- 1365-2133
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.